82 related articles for article (PubMed ID: 29793275)
1. Insurance coverage for pharmacogenomic testing in the USA.
Williams MS
Per Med; 2007 Nov; 4(4):479-487. PubMed ID: 29793275
[TBL] [Abstract][Full Text] [Related]
2. Stakeholder views on pharmacogenomic testing.
Patel HN; Ursan ID; Zueger PM; Cavallari LH; Pickard AS
Pharmacotherapy; 2014 Feb; 34(2):151-65. PubMed ID: 24167008
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory.
Vo TT; Bell GC; Owusu Obeng A; Hicks JK; Dunnenberger HM
Pharmacotherapy; 2017 Sep; 37(9):1014-1022. PubMed ID: 28699700
[TBL] [Abstract][Full Text] [Related]
4. Assessing patient readiness for the clinical adoption of personalized medicine.
Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
[TBL] [Abstract][Full Text] [Related]
5. Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer.
Lu CY; Loomer S; Ceccarelli R; Mazor KM; Sabin J; Clayton EW; Ginsburg GS; Wu AC
J Pers Med; 2018 May; 8(2):. PubMed ID: 29772692
[TBL] [Abstract][Full Text] [Related]
6. On pharmacogenomics in pharmacy benefit management.
Russell Teagarden J; Stanek EJ
Pharmacotherapy; 2012 Feb; 32(2):103-11. PubMed ID: 22392418
[TBL] [Abstract][Full Text] [Related]
7. Implementation of pharmacogenomics into the clinical practice of therapeutics: issues for the clinician and the laboratorian.
Wu AH; Babic N; Yeo KJ
Per Med; 2009 May; 6(3):315-327. PubMed ID: 29783510
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics instruction in US and Canadian medical schools: implications for personalized medicine.
Green JS; O'Brien TJ; Chiappinelli VA; Harralson AF
Pharmacogenomics; 2010 Sep; 11(9):1331-40. PubMed ID: 20860470
[TBL] [Abstract][Full Text] [Related]
9. Implementation of Clinical Pharmacogenomics within a Large Health System: From Electronic Health Record Decision Support to Consultation Services.
Hicks JK; Stowe D; Willner MA; Wai M; Daly T; Gordon SM; Lashner BA; Parikh S; White R; Teng K; Moss T; Erwin A; Chalmers J; Eng C; Knoer S
Pharmacotherapy; 2016 Aug; 36(8):940-8. PubMed ID: 27312955
[TBL] [Abstract][Full Text] [Related]
10. Personalized pharmacogenomics profiling using whole-genome sequencing.
Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
[TBL] [Abstract][Full Text] [Related]
11. Economic opportunities and challenges for pharmacogenomics.
Deverka PA; Vernon J; McLeod HL
Annu Rev Pharmacol Toxicol; 2010; 50():423-37. PubMed ID: 20055709
[TBL] [Abstract][Full Text] [Related]
12. Privacy issues in personalized medicine.
Vaszar LT; Cho MK; Raffin TA
Pharmacogenomics; 2003 Mar; 4(2):107-12. PubMed ID: 12605543
[TBL] [Abstract][Full Text] [Related]
13. The Implementation Process for Pharmacogenomic Testing for Cancer-Targeted Therapies.
Wu AC; Mazor KM; Ceccarelli R; Loomer S; Lu CY
J Pers Med; 2018 Oct; 8(4):. PubMed ID: 30275409
[TBL] [Abstract][Full Text] [Related]
14. Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice.
Frueh FW
Pharmacogenomics; 2010 May; 11(5):657-60. PubMed ID: 20415556
[TBL] [Abstract][Full Text] [Related]
15. Improving pharmacotherapy outcomes by pharmacogenomics: from expectation to reality?
Vizirianakis IS
Pharmacogenomics; 2005 Oct; 6(7):701-11. PubMed ID: 16207147
[TBL] [Abstract][Full Text] [Related]
16. A framework to evaluate the economic impact of pharmacogenomics.
Stallings SC; Huse D; Finkelstein SN; Crown WH; Witt WP; Maguire J; Hiller AJ; Sinskey AJ; Ginsburg GS
Pharmacogenomics; 2006 Sep; 7(6):853-62. PubMed ID: 16981846
[TBL] [Abstract][Full Text] [Related]
17. Healthcare payers: a gate or translational bridge to personalized medicine?
Canestaro WJ; Martell LA; Wassman ER; Schatzberg R
Per Med; 2012 Jan; 9(1):73-84. PubMed ID: 29783295
[TBL] [Abstract][Full Text] [Related]
18. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
Reiss SM;
J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomic variability and anaesthesia.
Searle R; Hopkins PM
Br J Anaesth; 2009 Jul; 103(1):14-25. PubMed ID: 19482856
[TBL] [Abstract][Full Text] [Related]
20. Mapping US commercial payers' coverage policies for medical interventions.
Chambers JD; Chenoweth MD; Neumann PJ
Am J Manag Care; 2016 Sep; 22(9):e323-8. PubMed ID: 27662396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
